Literature DB >> 17440198

Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia.

Barbara A Cornblatt1, Andrea M Auther, Tara Niendam, Christopher W Smith, Jamie Zinberg, Carrie E Bearden, Tyrone D Cannon.   

Abstract

INTRODUCTION: Research on prediction and prevention of schizophrenia has increasingly focused on prodromal (prepsychosis) social and role dysfunction as developmentally early, stable, and treatment-resistant illness components. In this report, 2 new measures, Global Functioning: Social and Global Functioning: Role, are presented, along with preliminary findings about psychometric properties and course of social and role (academic/work) functioning in the prodromal phase of psychosis.
METHODS: Subjects included 69 participants from the Recognition and Prevention program and 52 from the Center for the Assessment and Prevention of Prodromal States. Ages ranged from 12 to 29 years, and all met criteria for Attenuated Positive Symptom syndrome. Retrospective (past year) and baseline data are reported for all 121 prodromal subjects and for 44 normal controls (NCs). Prospective follow-up data are reported for a subsample of patients reevaluated at both 6 and 12 months (N = 44).
RESULTS: For both scales, interrater reliability was high, and preliminary data supported construct validity. Relative to NCs, prodromal individuals displayed impaired social and role functioning at baseline. Analyses of change over time indicated that role functioning declined over the year before ascertainment and improved over 12-month follow-up, presumably with treatment. Social impairment, by contrast, was constant across time and predicted later psychosis (P = .002). DISCUSSION: Using 2 new global measures, social functioning was found to be a stable trait, unchanged by treatment, with considerable potential to be a marker of schizophrenia. Role functioning, by contrast, may be a more direct barometer of clinical change and may be responsive to treatment and environmental change.

Entities:  

Mesh:

Year:  2007        PMID: 17440198      PMCID: PMC2526147          DOI: 10.1093/schbul/sbm029

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  41 in total

1.  Response to vocational rehabilitation during treatment with first- or second-generation antipsychotics.

Authors:  Gary R Bond; Hea-Won Kim; Piper S Meyer; P Joseph Gibson; Sandra Tunis; Jovier D Evans; Paul Lysaker; Marion L McCoy; Jerry Dincin; Haiyi Xie
Journal:  Psychiatr Serv       Date:  2004-01       Impact factor: 3.084

2.  The schizophrenia prodrome revisited: a neurodevelopmental perspective.

Authors:  Barbara A Cornblatt; Todd Lencz; Christopher W Smith; Christoph U Correll; Andrea M Auther; Emilie Nakayama
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

3.  Treatment effects on the social adjustment of depressed patients.

Authors:  M M Weissman; G L Klerman; E S Paykel; B Prusoff; B Hanson
Journal:  Arch Gen Psychiatry       Date:  1974-06

4.  The prediction of outcome in schizophrenia. I. Characteristics of outcome.

Authors:  J S Strauss; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1972-12

Review 5.  Symptom assessment in schizophrenic prodromal states.

Authors:  T J Miller; T H McGlashan; S W Woods; K Stein; N Driesen; C M Corcoran; R Hoffman; L Davidson
Journal:  Psychiatr Q       Date:  1999

6.  Measurement of premorbid adjustment in chronic schizophrenia.

Authors:  H E Cannon-Spoor; S G Potkin; R J Wyatt
Journal:  Schizophr Bull       Date:  1982       Impact factor: 9.306

7.  Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna Lifshey Rosen; Lubna Somjee; Philip J Markovich; Kelly Stein; Scott W Woods
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

8.  The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version.

Authors:  W J Chambers; J Puig-Antich; M Hirsch; P Paez; P J Ambrosini; M A Tabrizi; M Davies
Journal:  Arch Gen Psychiatry       Date:  1985-07

9.  A heuristic vulnerability/stress model of schizophrenic episodes.

Authors:  K H Nuechterlein; M E Dawson
Journal:  Schizophr Bull       Date:  1984       Impact factor: 9.306

10.  Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia.

Authors:  Todd Lencz; Christopher W Smith; Andrea Auther; Christoph U Correll; Barbara Cornblatt
Journal:  Schizophr Res       Date:  2004-05-01       Impact factor: 4.939

View more
  220 in total

1.  Abnormal movements are associated with poor psychosocial functioning in adolescents at high risk for psychosis.

Authors:  Vijay A Mittal; Maria Jalbrzikowski; Melita Daley; Cristina Roman; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2011-06-01       Impact factor: 4.939

2.  Dynamic association between interpersonal functioning and positive symptom dimensions of psychosis over time: a longitudinal study of healthy adolescents.

Authors:  Dina Collip; Johanna T W Wigman; Ashleigh Lin; Barnaby Nelson; Margreet Oorschot; Wilma A M Vollebergh; Jaymee Ryan; Gennedy Baksheev; Marieke Wichers; Jim van Os; Inez Myin-Germeys; Alison R Yung
Journal:  Schizophr Bull       Date:  2011-09-19       Impact factor: 9.306

3.  Risk factors for psychosis: impaired social and role functioning.

Authors:  Barbara A Cornblatt; Ricardo E Carrión; Jean Addington; Larry Seidman; Elaine F Walker; Tyronne D Cannon; Kristin S Cadenhead; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Scott W Woods; Robert Heinssen; Todd Lencz
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

Review 4.  Predicting the risk of psychosis onset: advances and prospects.

Authors:  Eric V Strobl; Shaun M Eack; Vaidy Swaminathan; Shyam Visweswaran
Journal:  Early Interv Psychiatry       Date:  2012-07-08       Impact factor: 2.732

5.  Family Aided Community Treatment for the Treatment of Early Psychosis: A Proof of Concept Study.

Authors:  Ryan P Melton; Cass Dykeman
Journal:  Community Ment Health J       Date:  2016-01-06

6.  Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis.

Authors:  Ricardo E Carrión; Barbara A Cornblatt; Danielle McLaughlin; Jeremy Chang; Andrea M Auther; Ruth H Olsen; Daniel C Javitt
Journal:  Schizophr Res       Date:  2015-02-23       Impact factor: 4.939

7.  Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis.

Authors:  Laina McAusland; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2016-08-29       Impact factor: 2.732

8.  Schizotypal personality disorder in individuals with the Attenuated Psychosis Syndrome: Frequent co-occurrence without an increased risk for conversion to threshold psychosis.

Authors:  Anthony W Zoghbi; Joel A Bernanke; Julia Gleichman; Michael D Masucci; Cheryl M Corcoran; Allegra Califano; Justin Segovia; Tiziano Colibazzi; Michael B First; Gary Brucato; Ragy R Girgis
Journal:  J Psychiatr Res       Date:  2019-04-21       Impact factor: 4.791

9.  Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.

Authors:  Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman
Journal:  Schizophr Res       Date:  2018-08-02       Impact factor: 4.939

10.  A comparison of neurocognition and functioning in first episode psychosis populations: do research samples reflect the real world?

Authors:  Emily Kline; Victoria Hendel; Michelle Friedman-Yakoobian; Raquelle I Mesholam-Gately; Ann Findeisen; Suzanna Zimmet; Joanne D Wojcik; Tracey L Petryshen; Tsung-Ung W Woo; Jill M Goldstein; Martha E Shenton; Matcheri S Keshavan; Robert W McCarley; Larry J Seidman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-11-28       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.